SC 13G Filing

Company

Celldex Therapeutics, Inc.

Filed

June 19, 2020

Accession Number

0001493152-20-011453

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →